Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Peter Libby MD
Peter Libby MD Advisory Board
J. William McEvoy MB BCh BAO, MEd, MHS, PhD, FRCPI
J. William McEvoy MB BCh BAO, MEd, MHS, PhD, FRCPI Advisory Board
Deepak Bhatt MD, MPH, FACC, FAHA, FESC, MSCAI
Deepak L. Bhatt MD, MPH, FACC, FAHA, FESC, MSCAI Advisory Board
See All Experts
story of the week
Published in Cardiology

Journal Scan / Research · April 21, 2022

Effect of Alirocumab Added to High-Intensity Statin on Coronary Atherosclerosis in Patients With AMI

JAMA: The Journal of the American Medical Association

 

 Save  Recommend
 Share

Additional Info

Disclosure statements are available on the authors' profiles:

Peter Libby MD

JAMA: The Journal of the American Medical Association
Effect of Alirocumab Added to High-Intensity Statin Therapy on Coronary Atherosclerosis in Patients With Acute Myocardial Infarction: The PACMAN-AMI Randomized Clinical Trial
JAMA 2022 Apr 03;[EPub Ahead of Print], L Räber, Y Ueki, T Otsuka, S Losdat, JD Häner, J Lonborg, G Fahrni, JF Iglesias, RJ van Geuns, AS Ondracek, MD Radu Juul Jensen, C Zanchin, S Stortecky, D Spirk, GCM Siontis, L Saleh, CM Matter, J Daemen, F Mach, D Heg, S Windecker, T Engstrøm, IM Lang, KC Koskinas

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading

Most Read This Week

Recently Updated